Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Home
/
About the Reporter
/
Park Pyeongtak
Park Pyeongtak
Reporter
Biowatch Team
With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail
ppt@kormedi.com
Latest Articles
“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market
11/9/2026
Could Space-Made Medicines Reach Patients Within 10 Years? Industry Experts Say Yes
11/8/2026
Seven-Day Fexuclue Regimen Cuts H. pylori Eradication Time in Half
11/5/2026
Daewoong Pharmaceutical to Build Aseptic Manufacturing Facility for Semaglutide Microneedle Patch
10/19/2026
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
10/16/2026
Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment
10/12/2026
FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients
10/8/2026
Dongkook Pharmaceutical’s Madeca Pharmacia Expands to Hyundai Department Store’s ‘Khōde’
10/8/2026
1
2
3
Next